These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29575941)

  • 21. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration.
    Iordanous Y; Powell AM; Mao A; Hooper PL; Eng KT; Schwartz C; Kertes PJ; Sheidow TG
    Can J Ophthalmol; 2014 Aug; 49(4):367-76. PubMed ID: 25103655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES
    Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
    Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
    Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: a prospective study.
    Veritti D; Sarao V; Parravano M; Arias L; Varano M; Lanzetta P
    Eur J Ophthalmol; 2017 Jan; 27(1):74-79. PubMed ID: 27791249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric Analysis of Vascularized Serous Pigment Epithelial Detachment Progression in Neovascular Age-Related Macular Degeneration Using Optical Coherence Tomography Angiography.
    Au A; Hou K; Dávila JP; Gunnemann F; Fragiotta S; Arya M; Sacconi R; Pauleikhoff D; Querques G; Waheed N; Freund KB; Sadda S; Sarraf D
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3310-3319. PubMed ID: 31369033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OUTCOME OF INTRAVITREAL AFLIBERCEPT FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OR WITHOUT SUBRETINAL FLUID AND SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kim K; Kim ES; Kim Y; Yang JH; Yu SY; Kwak HW
    Retina; 2019 Feb; 39(2):303-313. PubMed ID: 29160779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration.
    Cho HJ; Kim KM; Kim HS; Lee DW; Kim CG; Kim JW
    Am J Ophthalmol; 2016 Jun; 166():112-119. PubMed ID: 27048998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
    Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
    Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
    Waldstein SM; Simader C; Staurenghi G; Chong NV; Mitchell P; Jaffe GJ; Lu C; Katz TA; Schmidt-Erfurth U
    Ophthalmology; 2016 Jul; 123(7):1521-9. PubMed ID: 27157149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB: Time Course and Drug Effects.
    de Massougnes S; Dirani A; Ambresin A; Decugis D; Marchionno L; Mantel I
    Retina; 2016 May; 36(5):881-8. PubMed ID: 27115852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose ranibizumab therapy for vascularized pigment epithelial detachment.
    Chan CK; Abraham P; Sarraf D
    Eye (Lond); 2012 Jun; 26(6):882-5. PubMed ID: 22576827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration.
    Zinkernagel MS; Wolf S; Ebneter A
    Ophthalmologica; 2016; 235(1):42-8. PubMed ID: 26540259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration.
    Panos GD; Gatzioufas Z; Petropoulos IK; Dardabounis D; Thumann G; Hafezi F
    Drug Des Devel Ther; 2013; 7():565-9. PubMed ID: 23874084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
    Wolf A; Rüping J; Neubauer AS; Mayer W; Ulbig M; Haritoglou C; Holz FG; Eter N; Kampik A
    Retina; 2013 Oct; 33(9):1843-9. PubMed ID: 23598795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.